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Four-Substituted derivatives of salicylic and anthranilic acids: 2-hydroxy-5-azidosulfonylbenzoic acid 
(HASBA, 1), 2-acetyloxy-5- azidosulfonylbenzoic acid (AASBA, 2), 2-acetamido-5- azidosulfonylbenzoic 
acid (AMASBA, 3) and 2-acetamido-5-sulfonamidobenzoic acid (AMSABA, 4) were synthesized and 
evaluated for their analgesic, antipyretic, anti-inflammatory and cytotoxic activities. HASBA, AASBA 
and AMASBA showed higher analgesic activity than aspirin (ASA) at 100 mg/kg dose, while AMSABA 
showed the least analgesic property. AMASBA exhibited higher antipyretic activity than paracetamol 
(PCM), while HASBA, AASBA and AMSABA also showed antipyretic effects which were of equal 
potency to that of PCM. The order of anti-inflammatory effects of the four compounds is: AASBA > 
AMASBA > HASBA > AMSABA. The effects of the substituents on the biological activities of the 
synthesized compounds are discussed. 
 





Salicylates are the class of compounds that are widely 
valued for their pain killing, antipyretic and anti-
inflammatory properties (Moncada and Vane 1979;  Insel, 
1991). The most commonly known and used salicylates 
are salicylic acid (also called 2-hydroxybenzoic acid), 
aspirin (acetylsalicylic acid -ASA) and sodium 
salicyclates. They are used extensively for the relief of 
headache, inflammation, arthritis pain, and some are 
employed in the treatment of heart attacks and strokes in 
the elderly (Rainsford, 1984).  
Their mode of action is the inhibition of the synthesis of 
prostaglandin and its derivatives that cause inflammation, 
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and Vane, 1979; Meade et al., 1993). Recently, salicylic 
acid has been used primarily as an intermediate in the 
production of agrochemicals, dyes and colorants 
products (Cremlyn, 1991; Raskin, 1992). Salicylate 
toxicity and poisoning are rare in recommended doses, 
however, salicylate poisoning and its side effects are 
prominent problem in developing countries where they 
are used as antipyretic in the management of infectious 
malaria, both in children and in elderly people. 
Meanwhile, there are development and introduction of 
new analgesic, antipyretic and anti-inflammatory agents 
that compete with aspirin. This has made chemists to 
search for a better tolerable drug which are devoid of 
toxic and side effects of aspirin has been shown in the 
CNS, respiratory, gastro-intestinal tract, hepatic, 
metabolic and coagulation systems of the body 
(Goldfrank et al., 1990).  This  work  is  the  first  stage  in  
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                                 Figure 1.  Outline for the Synthesis of Compounds 1-4 
 
 
Table 1. Ortho-Substituted Benzoic Acid Derivatives (1 – 4). 
 
Compd. Yield (%) Mp (0C) X Y Formula C (%) H  (%) N (%) 
1 76 176 – 179a OH N3 C7H5N3O5 S 34.57 (34.21) 2.07 (1.98) 17.28 (17.10) 
2 48 (68) 131 -   132 OCOCH3 N3 C9H7N3O6 S 37.89 (38.05) 2.47 (2.58) 14.74 (14.58) 
3 46 279 – 281 (dec) NHCOCH3 N3 C9H8N4O5 S 38.02 (38.11) 2.84 (2.55) 19.71 (19.42) 
4 68 >300 (dec) NHCOCH3 NH2 C9H10N2O5 S 41.85 (41.96) 3.90 (3.68) 10.85 (10.44) 
 
a: Obafemi and Onigbinde, 1991. 
 
evaluating the various biological activities produced by 
four derivatives of salicylic acid synthesized in our 
laboratories. These compounds are tested to examine 
their potency, efficacy and cytotoxicity with a view of 
developing a compound having lower toxicity and less 
side effects. This communication therefore describes the 
synthesis of 2-hydroxy-5-azidosulfonylbenzoic acid 
(HASBA,  1), 2-acetyoxy-5- azidosulfonylbenzoic acid 
(AASBA,  2 ), 2-acetamide-5- azidosulfonylbenzoic acid 
(AMASBA,  3) and 2-acetamido-5-sulfonamidobenzoic 
acid (AMSABA,  4 ) and their effects on pain, temperature 




MATERIALS AND METHODS 
 
Synthesis of derivatives of Salicylic and anthranilic acids 
 
The four sulfonyl derivatives of salicylic acid and anthranilic acid, 1- 
4, were synthesized following a procedure described earlier 
(Obafemi and Onigbinde, 1991). This involves chlorosulfonation of 
2-amino or 2-hyroxybenzoic acid with excess chlorosulfonic acid, to 
give the corresponding 2 substituted  5 chlorosulfonylbenzoic acid 
derivatives. This is followed by reaction with either sodium azide in 
aqueous acetone or with ammonium hydroxide to afford 1-4 (Figure 





Swiss albino mice (18-24g) and Wistar albino rats (180-220g) of 
either sex were obtained and bred in the Faculty of Pharmacy 
Animal House. Food and water were provided ad libitum. 
Experiments were carried out between 10.00 and 17.00 h. 
 
 
Antipyretic activity in rats 
 
Rats were given s.c. 20 ml/kg of a 20% aqueous suspension of 
sterilized brewer’s yeast powder. After 18 h, animals showing an 
increase of rectal temperature > 0.50C were selected. Control group 
received normal saline; treated groups received 25, 50 and 100 
mg/kg of compounds 1 to 4, respectively. Rectal temperature was 
determined by thermal-probe (Ellab thermistor thermometer) 30 min 






Tests were carried out by the following methods: 
 




Table 2. The Effects of Salicylic acid and Anthranilic acid Derivatives on Acetic acid (chemical) induced writhing, hot-plate and tail 
immersion (thermal) induced pain response in mice. 
      
Treatment Dose (mg/kg) Writhing response 
(No/20 min) 
Tail immersion 
reaction time (sec) 
Hot - Plate reaction 
time (sec) 
Control (DMSO) 0.3 ml 58.4 ±1.75 3.6 ± 0.36 9.6 ±0.92 
HASBA 




54.8 ± 3.91 
36.8 ± 8.66* 
30.4 ± 8.52** 
2.4 ± 0.22 
8.8 ± 1.72** 
4.2 ± 0.44 
8.0 ± 0.49 
11.3 ±1.78 
14.6 ± 1.04** 
AASBA 




48.3 ± 1.98** 
32.8 ±7.7** 
24.4 ± 5.44** 
5.6 ± 1.12 
10.2 ± 2.94* 
7.0 ± 1.66* 
19.6 ± 0.83** 
24.2 ± 1.43** 
24 8 ± 0.77** 
AMASBA 





38.0 ± 5.87** 
24.5 ±9.42** 
3.8 ± 0.33 
4.8 ± 0.18 
7.0 ±2.02 








42.7 ± 3.72** 
38.8 ±5.95** 
38.0 ± 2.83** 
3.8 ±0.18 
2.6 ± 0.22 




Acetylsalicylic acid  (ASA) 100 32.0 ± 2.5** 36.0 ± 1.5** 16.2 ±2.9** 
 
           Values represent the Mean ± S.E.M, (n = 5). *p < 0.05; **p < 0.01. 
 
 
Hot Plate Test: Male and female albino mice showing reaction time 
of 10 sec to thermal stimulus of 55 ± 10C were selected. Groups of 
mice (5 mice per group) were given doses of 25, 50 and 100 mg/kg. 
i.p., and saline to the control group. The reaction time for control 
and treated mice were recorded after 1 h of drug administration. 
 
Acetic acid induced writhing: Using the method of Siegmund et 
al. (1957), three graded doses (25, 50 and 100 mg/kg) of the 
compounds 1 - 4 were administered intraperitoneally to 16 h fasted 
mice, divided into 5 groups of 5 mice each. The first three groups 
received 3 doses of each compound, the 4th and 5th groups served 
as the negative and positive controls and they received 0.3 ml 
normal saline and 100 mg/kg ASA, respectively. One hour after 
treatment, animals in each group received 0.1 ml of 3% acetic acid 
to induce the characteristic writhing response. The number of 
writhings occurring for 30 min was recorded. This same procedure 
was repeated for the other three compounds. 
 
Tail immersion test: The tail of the mice (about 5 cm long) was 
immersed into water bath of 55 + 10C, the time (s) taken to 
withdraw the tail clearly out of the water bath was taken as the 
reaction time. The mice were first treated with different doses of the 
compounds (25, 50 and 100 mg/kg s.c.), and after one hour of 
compound administration, their tails were immersed in the hot water 
bath and the reaction time recorded. ASA (100 mg/kg s.c.) was 





Inflammation in the hind paw of albino rat was induced as described 
by Winter et al. (1962). 0.1 ml of 1% carrageenan suspension was 
injected into sub-plantar surface of the right hind limb of each rat. 
The control group received 0.3 ml normal saline, the treated and 
positive control groups received 25, 50 and 100 mg/kg of 
compounds 1 - 4 and 100 mg/kg of phenylbutazone (PBZ) 
respectively by subcutaneous route, 30 min before carrageenan 
injection. The volume of each paw was measured by using a thread 
to determine the diameter of oedema formation size at 0, 0.5, 1, 2, 
3 and 4 h. The difference in diameter of the left and the right hind 
paws was taken as a measure of oedema every 30 min for 4 h. 
 
Cytotoxicity Test  
 
The cytotoxicity of the 4 compounds was monitored by 
haemagglutination activity using formaldehyde fixed bovine 
erythrocytes as described by Peumans et al. (1982), Sadique et al. 
(1989) and Wang et al. (1995). 
 
 
Statistical  analysis  
 
Student’s  t-test was employed for statistical analysis of the data. A 
probability value less than 0.05 or 0.001 was considered statistically 






Acetylsalicylic acid (Bento Pharmaceuticals), carrageenan (Sigma), 
DMSO (BDH), yeast (Food Science and Technology Department, 
O.A.U, Ile-Ife), paracetamol (Bento Pharmaceuticals), 





Four substituted derivatives of salicylic and anthranilic 
acid possess analgesic activity. The compounds 1- 4 
(HASBA, AASBA, AMASBA and AMSABA respectively) 
significantly reduced pain induced by acetic acid writhing 
responses. The number of writhing episode in treated 
mice decreased significantly (P<0.05) compared to ASA. 
HASBA, AASBA and AMASBA were more active in 
decreasing the number of writhing than ASA, with 
AMASBA showing the highest activity (Table 2). Likewise 
all the compounds exhibited potent analgesic effect 
against thermal noxious stimuli in hot plate model. In this 
model, AASBA and AMASBA exhibited higher analgesic 





Table 3. Antipyretic activities of Acetylsalicylic and Anthranilic acids Derivatives and Paracetamol on Yeast induced pyrexia in rats.  
 
 
Values represent the rectal temperature  mean ± S.E.M, (n = 5). *p < 0.05. 
 
 
effect against thermal stimuli than ASA. However, in the 
tail immersion technique ASA was more potent than all 
the synthesized compounds. 
The results of the antipyretic activity of the compounds 
are presented in Table 3. Administration of the yeast to 
the rats produced significant increase in rectal 
temperature 18 h after yeast injection. All the compounds 
showed antipyretic effect like the reference drug (PCM). 
However, AMASBA showed the highest activity even 
more than that of the reference drug. 
The anti-inflammatory effects of the compounds on 
carageenan-induced oedema in the rat’s right hind paw 
are presented in Table 4. There was a gradual increase 
in oedema paw volume of rats in the control group. 
However, in the treated groups, all the 4 compounds 
produced a significant reduction in oedema formation 
except AMSABA. The order of potency is: AASBA > 
AMASBA > HASBA > AMSABA. However, the effects of 
these compounds were less compared to that of 
phenylbutazone. The cytotoxicity (haemagglutination) 
assay performed for HASBA, AASBA, AMASBA, 
AMSABA and ASA exhibited no agglutination on the 




Pain, swelling (oedema) and fever (pyrexia) are the signs 
and symptoms of both acute and chronic inflammation, 
malaria and stress. Acetylsalicylic acid (ASA) and other 
non-steroidal anti-inflammatory drugs (NSAID) are 
prominent agents used for or in combination with agents 
used in treating these symptoms.  The study revealed 
that synthesized HASBA, AASBA, AMASBA and 
AMSABA compounds were active and possess 
antipyretic, analgesic, anti-inflammatory properties. It was 
also detected that some of the compounds evaluated 
were more potent, and less toxic than ASA except 
AMASBA, which killed all the experimental animals at 
100 mg/kg dose level. 
According to these findings, analgesic effects were 
assessed in chemical and thermal models of nociception  
using acetic acid induced writhing, hot plate and tail 
immersion tests. The results show that the compounds 
did not exhibit significant analgesic property in tail 
immersion test. In acetic acid induced writhing, a dose-
related analgesic effect of the compounds 1 – 4 was 
observed. Collier et al. (1968) proposed that acetic acid 
acts indirectly by inducing the release of endogenous 
mediators peripherally and stimulates the pain neurons 
sensitive to NSAID agents. Likewise, in the hot plate 
model, the compounds also exhibited dose-related 
analgesic effect. These models are useful tools to access 
the potency of the compounds, their probable sites and 
mechanism of action. It seems therefore, according to 
Martins Do Monte et al. (2004), that these compounds 
may be producing their effects both  
peripherally (through acetic acid induced writhing) and 
centrally (using both tail immersion and hot plate tests). 
The compounds tested also produced significant 
antipyretic and anti-inflammatory effects (Tables 3 and 4). 
These   compounds    may   exhibit    both    central    and  
Treatment Dose 
(mg/kg) 
Before drug (OC) After drug (OC) 
 - 18 h 0 h 0.5 h 1 h 2 h 3 h 4 h 
Control (DMSO) 0.3 ml 37.8±0.14 38.2±0.05 38.7±0.03 38.5±0.06 38.5±0.05 38.5±0.05 38.3±0.04 
HASBA 











































































































37.6±0.4 37.5±0.3* 37.2±0.2* 37.5±0.2* 37.3±0.3* 37.2±0.4* 




Table 4. Anti-inflammatory activities of Salicylic acid and Anthranilic acid derivatives on Carrageenan-induced oedema 
































Mean ± S.E.M, (n = 5). *p < 0.05; **p < 0.01. 
 
 
peripheral actions because pyrexia and inflammation are 
central and peripheral processes, respectively. The 
compounds show suppressant activity on acute 
inflammatory model of carrageenan-induced paw 
oedema in rats and produced significant antipyretic 
activity higher than that exhibited by PCM. From these 
observations it can be indeed inferred that the 
endogenous chemical substances liberated during pain, 
inflammation and fever like histamine, serotonin and 
arachidonic cascade metabolites are inhibited to produce 
various activities highlighted in this study. 
In order to establish some structural activity relationship 
from the results presented in the study, the activity of the 
compounds are correlated with the functional groups at 
the C-2 and C–5 positions on the benzene ring, 
compared to aspirin (ASA). It has been suggested by 
Insel (1991) that substitution on carboxyl or hydroxyl 
group changes the potency or toxicity of ASA 
compounds. The ortho position of the OH group is an 
important feature for the action of salicylates, even 
benzoic acid shares many of the actions of salicylic acid 
but is much weaker.  
In general, the introduction of the sulfonyl azide 
functional group (-SO2N3) at position 5 of the benzene 
ring (as in structures 1, 2 and 3) results in a higher 
analgesic activity compared to ASA (Table 2). 
Introduction of the acetamido (-NHCOCH3) functional 
group as in 3, instead of the acetyloxy functional   group  
(-OCOCH3) as in 2 seems to increase the analgesic 
activity in acetic acid-induced writhing test only. However, 
compound 2 exhibited higher activity over 3 at 50 mg/kg 
in hot plate, tail immersion analgesic tests (Table 2) and 
in the anti-inflammatory test (Table 4).  Our observation 
from this study is that few minutes after compound 3 was 
administered, all the animals died at 100mg/kg dose level 
only. On the other hand, changing the sulfonyl azide 
group in 3 into the sulphonamide group (-SO2NH2), as in 
4 decreased the analgesic and anti-inflammatory 
activities and did not show such toxicity exhibited by 
compound 3. 
The cytotoxicity assay was used to assess the effect of 
compounds 1 – 4 and ASA on membrane stability of 
bovine RBC in relation to its ability to maintain the 
integrity or preventing the lysing of the cells. It is one of 
the mechanisms to explain their anti-inflammatory 
property. NSAID has been shown to stabilize the cell 
membrane protein (Bowman and Rand, 1980). Even 
though acetylsalicylic acid (1 mg/ml) is known to possess 
a weaker membrane stabilizing activity (Sadique et al., 
1989), the results in this study indicated that not all the 
compounds and ASA lysed the RBC hence they are 
capable of preventing membrane damage caused by 
injury during inflammation. 
In conclusion, the results of the present investigation 
suggest that derivatives of acetylsalicylic and anthranilic 
acids    such    as    HASBA,    AASBA    and     AMSABA  










0.3 ml 0.26±0.08 0.70±0.21 1.12±0.12 0.90±0.16 0.84v0.16 0.76±0.15 
HASBA 


































































































(Compounds 1, 2 and 4) have promising analgesic, 
antipyretic and anti-inflammatory properties. However, 
AMASBA (Compound 3) produced potent and promising 
similar pharmacological properties, but was found to kill 
the animals at 100 mg/kg probably due to the presence of 
the acetamido (-NHCOCH3) group. Further studies on the 
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